Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bravo At Last For GSK As MATINEE Succeeds In COPD

06 Sep 2024

• By Andrew McConaghie

New GSK sign

Related Content

GSK Tailors SWIFT Readout Towards Asthma Approval

21 May 2024

Amgen/AstraZeneca’s Tezspire Shows Efficacy In Broader COPD Population

20 May 2024

Related Companies

GSK plc

Verona Pharma plc

Sanofi

Regeneron Pharmaceuticals, Inc.

AstraZeneca PLC

Additional Topics

Clinical Trials Companies Research & Development Respiratory BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.